Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

RENALSTEM

Financiado

Cerrado

Developing a stem cell based therapy to replace nephrons lost through reflux nep...

Developing a stem cell based therapy to replace nephrons lost through reflux nephropathy The prevalence of end stage renal disease (ESRD) continues to grow worldwide. Current treatment options for ESRD are peritoneal dialysis, haemodialysis, or renal transplantation, all of which have significant drawbacks both in ter... ver más

31/07/2010

THE UNIVERSITY OF...

168K€

Presupuesto del proyecto: 168K€

Líder del proyecto

THE UNIVERSITY OF LIVERPOOL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2010-07-31 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

THE UNIVERSITY OF LIVERPOOL

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

STAR-T REK Set up and comparison of multiple stem cell approaches for k... 4M€ Cerrado

STELLAR Stem cell based therapy for kidney repair 10M€ Cerrado

REGMAMKID How to regenerate the mammalian kidney 1M€ Cerrado

GECKO Generation of cartilage-free kidney organoids: a small molec... 203K€ Cerrado

KIDREGEN Ivestigating the ability of embryonic stem cell derivatives... 30K€ Cerrado

NEOGRAFT NEONATAL KIDNEY STEM PROGENITOR CELLS AS A NOVEL TYPE OF CEL... 2M€ Cerrado

Líder del proyecto

THE UNIVERSITY OF LIVERPOOL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 168K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The prevalence of end stage renal disease (ESRD) continues to grow worldwide. Current treatment options for ESRD are peritoneal dialysis, haemodialysis, or renal transplantation, all of which have significant drawbacks both in terms of quality and quantity of life. In children and young adults, the most common cause of ESRD is vesicoureteric reflux (VUR), a condition where urine from the bladder re-enters the kidney. VUR creates an increased risk of urinary tract infection, predisposing to pyelonephritis, renal scarring, and in the most severe cases, ESRD. However, there is usually a time-window of several years from initial diagnosis of VUR to the development of ESRD, which presents an opportunity to design therapies aimed at preventing disease progression by repairing renal tissue before it becomes non functional. Recent advances in stem cell science and tissue engineering suggests that stem cell based therapies for reflux nephropathy could be feasible. The long-term aim is to explore the potential of resident kidney stem cells for renal replacement therapy in order to prevent susceptible children from developing ESRD. In this project, the potential of resident kidney stem cells will be tested by transplantation into mouse embryonic kidneys ex vivo. To devise a suitable scaffold to, a range of biocompatible polymeric substrates will be fabricated and tested for their ability to support nephrogenesis from disaggregated mouse kidney rudiments in vitro. Finally, we will develop a magnetic nanoparticle-based cell tracking technique that will enable the transplanted cells to be monitored in vivo using magnetic resonance imaging. Results generated by the project will establish if kidney stem cells have potential for future use in regenerative medicine. Should the results prove positive, further work will determine if the isolated kidney stem are capable of generating nephrons in animal models in vivo.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores